Search Results - "Leyen, Klaus"

Refine Results
  1. 1

    Lipoxygenase: an emerging target for stroke therapy by van Leyen, Klaus

    Published in CNS & neurological disorders drug targets (01-03-2013)
    “…Neuroprotection as approach to stroke therapy has recently seen a revival of sorts, fueled in part by the continuing necessity to improve acute stroke care,…”
    Get more information
    Journal Article
  2. 2

    Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke by Cheng, Guangsen, Zhao, Wei, Xin, Yongjie, Huang, Guomin, Liu, Yongkang, Li, Zhongliang, Zhan, Meixiao, Li, Yong, Lu, Ligong, Leyen, Klaus, Liu, Yu

    Published in Journal of neurochemistry (01-05-2021)
    “…Thrombolytic stroke therapy with tissue plasminogen activator (tPA) is limited by risks of hemorrhagic transformation (HT). We have reported that a new…”
    Get full text
    Journal Article
  3. 3

    Cell-cell signaling in the neurovascular unit by Lok, Josephine, Gupta, Punkaj, Guo, Shuzhen, Kim, Woo Jean, Whalen, Michael J, van Leyen, Klaus, Lo, Eng H

    Published in Neurochemical research (01-12-2007)
    “…Historically, the neuron has been the conceptual focus for almost all of neuroscience research. In recent years, however, the concept of the neurovascular unit…”
    Get full text
    Journal Article
  4. 4

    The role of Ca2+ in cell death caused by oxidative glutamate toxicity and ferroptosis by Maher, Pamela, van Leyen, Klaus, Dey, Partha Narayan, Honrath, Birgit, Dolga, Amalia, Methner, Axel

    Published in Cell calcium (Edinburgh) (01-03-2018)
    “…[Display omitted] •Oxytosis/ferroptosis causes cell death by glutathione depletion and Ca2+ influx.•Ca2+ influx occurs through channels involved in…”
    Get full text
    Journal Article
  5. 5

    The future of neuroprotection in stroke by Chamorro, Ángel, Lo, Eng H, Renú, Arturo, van Leyen, Klaus, Lyden, Patrick D

    “…Investigators acknowledge the limitations of rodent or non-human primate stroke models, hundreds of putative neuroprotectants have been evaluated in…”
    Get full text
    Journal Article
  6. 6

    Genetic ablation and short-duration inhibition of lipoxygenase results in increased macroautophagy by Jang, Insook, Park, Sujin, Cho, Jin Won, Yigitkanli, Kazim, van Leyen, Klaus, Roth, Jürgen

    Published in Experimental cell research (15-02-2014)
    “…12/15-lipoxygenase (12/15-LOX) is involved in organelle homeostasis by degrading mitochondria in maturing red blood cells and by eliminating excess peroxisomes…”
    Get full text
    Journal Article
  7. 7

    Following experimental stroke, the recovering brain is vulnerable to lipoxygenase‐dependent semaphorin signaling by Pekcec, Anton, Yigitkanli, Kazim, Jung, Joo Eun, Pallast, Stefanie, Xing, Changhong, Antipenko, Alexander, Minchenko, Maria, Nikolov, Dimitar B., Holman, Theodore R., Lo, Eng H., Leyen, Klaus

    Published in The FASEB journal (01-02-2013)
    “…Recovery from stroke is limited, in part, by an inhibitory environment in the postischemic brain, but factors preventing successful remodeling are not well…”
    Get full text
    Journal Article
  8. 8
  9. 9

    CPEB4 Is a Cell Survival Protein Retained in the Nucleus upon Ischemia or Endoplasmic Reticulum Calcium Depletion by Kan, Ming-Chung, Oruganty-Das, Aparna, Cooper-Morgan, Amalene, Jin, Guang, Swanger, Sharon A., Bassell, Gary J., Florman, Harvey, van Leyen, Klaus, Richter, Joel D.

    Published in Molecular and Cellular Biology (01-12-2010)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  10. 10

    Neuronal Production of Lipocalin-2 as a Help-Me Signal for Glial Activation by Xing, Changhong, Wang, Xiaoshu, Cheng, Chongjie, Montaner, Joan, Mandeville, Emiri, Leung, Wendy, van Leyen, Klaus, Lok, Josephine, Wang, Xiaoying, Lo, Eng H

    Published in Stroke (1970) (01-07-2014)
    “…BACKGROUND AND PURPOSE—We explored the hypothesis that injured neurons release lipocalin-2 as a help me signal. METHODS—In vivo lipocalin-2 responses were…”
    Get full text
    Journal Article
  11. 11

    Opening the time window by van Leyen, Klaus, Wang, Xiaoying, Selim, Magdy, Lo, Eng H

    “…Abstract The recently completed EXTEND trial tested the idea that tissue plasminogen activator thrombolysis can be safely extended up to 9 h after stroke onset…”
    Get full text
    Journal Article
  12. 12

    12/15-lipoxygenase inhibition attenuates neuroinflammation by suppressing inflammasomes by Cakir-Aktas, Canan, Bodur, Ebru, Yemisci, Muge, van Leyen, Klaus, Karatas, Hulya

    Published in Frontiers in cellular neuroscience (26-09-2023)
    “…Introduction: Lipoxygenases (LOXs) have essential roles in stroke, atherosclerosis, diabetes, and hypertension. 12/15-LOX inhibition was shown to reduce…”
    Get full text
    Journal Article
  13. 13
  14. 14

    STAT-Dependent Upregulation of 12/15-Lipoxygenase Contributes to Neuronal Injury after Stroke by Jung, Joo Eun, Karatas, Hulya, Liu, Yu, Yalcin, Ayfer, Montaner, Joan, Lo, Eng H, van Leyen, Klaus

    “…Oxidative stress is a major brain injury mechanism after ischemic stroke. 12/15-lipoxygenase (12/15-LOX) is a key mediator of oxidative stress, contributing to…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies by Rai, Ganesha, Joshi, Netra, Jung, Joo Eun, Liu, Yu, Schultz, Lena, Yasgar, Adam, Perry, Steve, Diaz, Giovanni, Zhang, Qiangli, Kenyon, Victor, Jadhav, Ajit, Simeonov, Anton, Lo, Eng H, van Leyen, Klaus, Maloney, David J, Holman, Theodore R

    Published in Journal of medicinal chemistry (22-05-2014)
    “…A key challenge facing drug discovery today is variability of the drug target between species, such as with 12/15-lipoxygenase (12/15-LOX), which contributes…”
    Get full text
    Journal Article
  17. 17

    Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke by Yigitkanli, Kazim, Pekcec, Anton, Karatas, Hulya, Pallast, Stefanie, Mandeville, Emiri, Joshi, Netra, Smirnova, Natalya, Gazaryan, Irina, Ratan, Rajiv R., Witztum, Joseph L., Montaner, Joan, Holman, Theodore R., Lo, Eng H., van Leyen, Klaus

    Published in Annals of neurology (01-01-2013)
    “…Targeting newly identified damage pathways in the ischemic brain can help to circumvent the currently severe limitations of acute stroke therapy. Here we show…”
    Get full text
    Journal Article
  18. 18

    12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress by Pallast, Stefanie, Arai, Ken, Wang, Xiaoying, Lo, Eng H, van Leyen, Klaus

    Published in Journal of neurochemistry (01-11-2009)
    “…12/15-Lipoxygenase (12/15-LOX) is an important mediator of brain injury following experimental stroke in rodents. It contributes to neuronal death, but the…”
    Get full text
    Journal Article
  19. 19

    Baicalein and 12/15-lipoxygenase in the ischemic brain by VAN LEYEN, Klaus, HAHN YOUNG KIM, LEE, Seong-Ryong, GUANG JIN, ARAI, Ken, LO, Eng H

    Published in Stroke (1970) (01-12-2006)
    “…The natural product baicalein is a specific inhibitor of 12/15-lipoxygenase, but it also has antioxidant properties. The current study was designed to test if…”
    Get full text
    Journal Article
  20. 20

    CD200 restrains macrophage attack on oligodendrocyte precursors via toll-like receptor 4 downregulation by Hayakawa, Kazuhide, Pham, Loc-Duyen D, Seo, Ji Hae, Miyamoto, Nobukazu, Maki, Takakuni, Terasaki, Yasukazu, Sakadžić, Sava, Boas, David, van Leyen, Klaus, Waeber, Christian, Kim, Kyu-Won, Arai, Ken, Lo, Eng H

    “…There are numerous barriers to white matter repair after central nervous system injury and the underlying mechanisms remain to be fully understood. In this…”
    Get full text
    Journal Article